February 27, 2021
Business News

Eurofins launches new tests and massive capacity for detecting and monitoring new variants of SARS-CoV-2


LUXEMBOURG–()–The increasing diversity of SARS-CoV-2 variants and the potential higher infectivity of some new viral strains, underline the need to identify, trace and track mutations across the complete viral genome. Currently, strains of concern include the B.1.1.7 variant, first identified in the United Kingdom, and the B.1.351 variant, first identified in South Africa.

Eurofins is pleased to announce the following initiatives to support health authorities’ variant detection and monitoring programmes:

– Increasing, to more than 5,000 full genomes per day, the capacity for its ARTIC Next Generation Sequencing (NGS)

– The launch of NovaType, a SARS-CoV-2 RT-PCR assay, clinically validated for the…



Click here to view the original article.

Related Posts

You might also like ...

Tractor Supply Supports Texas in Winter Storm Recovery
BeiGene Announces Closing of Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab in North America, Europe and Japan
AVer Europe: How to Prepare for Hybrid Workspaces